SEC Form 4 · accession 0001140361-15-037810
CytomX Therapeutics, Inc. · CTMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frederick W Gluck
Director
Period of report
Oct 14, 2015
Accepted (ET)
Oct 16, 2015 · 10:15 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001501989
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 14, 2015 | P | 10,000 | $12.00 | A | 147,791 | D | |
| Common StockF1 | Oct 14, 2015 | P | 5,000 | $12.00 | A | 5,000 | I | By Richlin Partners, LLC |
| Common Stock | holding | — | — | — | 3,200 | I | By spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Richlin Partners, LLC is an entity owned of record by the spouse of Frederick W. Gluck.
Remarks
Exhibit 24.1 - Power of Attorney (incorporated by reference to the Power of Attorney filed as Exhibit 24.1 to the Form 3 filed by the reporting person on October 7, 2015)